Northern Trust’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$27.7M Sell
1,275,090
-211,108
-14% -$4.58M ﹤0.01% 1457
2025
Q1
$36M Sell
1,486,198
-17,368
-1% -$421K 0.01% 1284
2024
Q4
$31.4M Buy
1,503,566
+119,766
+9% +$2.5M ﹤0.01% 1423
2024
Q3
$27.5M Sell
1,383,800
-2,907
-0.2% -$57.8K ﹤0.01% 1429
2024
Q2
$21.5M Sell
1,386,707
-43,041
-3% -$667K ﹤0.01% 1512
2024
Q1
$22.8M Buy
1,429,748
+11,007
+0.8% +$175K ﹤0.01% 1506
2023
Q4
$23.8M Sell
1,418,741
-18,424
-1% -$310K ﹤0.01% 1487
2023
Q3
$16.8M Buy
1,437,165
+30,262
+2% +$354K ﹤0.01% 1672
2023
Q2
$18.9M Buy
1,406,903
+14,248
+1% +$191K ﹤0.01% 1622
2023
Q1
$23.1M Sell
1,392,655
-1,659
-0.1% -$27.5K ﹤0.01% 1461
2022
Q4
$25.9M Buy
1,394,314
+27,453
+2% +$511K 0.01% 1377
2022
Q3
$17.5M Buy
1,366,861
+50,729
+4% +$651K ﹤0.01% 1584
2022
Q2
$9.23M Sell
1,316,132
-3,761
-0.3% -$26.4K ﹤0.01% 2088
2022
Q1
$10.9M Sell
1,319,893
-58,547
-4% -$485K ﹤0.01% 2087
2021
Q4
$9.33M Sell
1,378,440
-47,263
-3% -$320K ﹤0.01% 2277
2021
Q3
$7.56M Buy
1,425,703
+1,555
+0.1% +$8.24K ﹤0.01% 2471
2021
Q2
$8.19M Buy
1,424,148
+249,975
+21% +$1.44M ﹤0.01% 2511
2021
Q1
$5.41M Sell
1,174,173
-78,168
-6% -$360K ﹤0.01% 2698
2020
Q4
$4.18M Sell
1,252,341
-77,290
-6% -$258K ﹤0.01% 2782
2020
Q3
$3.95M Sell
1,329,631
-49,069
-4% -$146K ﹤0.01% 2682
2020
Q2
$6.37M Buy
1,378,700
+147,737
+12% +$683K ﹤0.01% 2366
2020
Q1
$4.74M Sell
1,230,963
-4,958
-0.4% -$19.1K ﹤0.01% 2328
2019
Q4
$4.63M Buy
1,235,921
+45,009
+4% +$169K ﹤0.01% 2629
2019
Q3
$6.32M Buy
1,190,912
+33,170
+3% +$176K ﹤0.01% 2412
2019
Q2
$4.44M Buy
1,157,742
+30,398
+3% +$117K ﹤0.01% 2622
2019
Q1
$5.75M Sell
1,127,344
-1,297
-0.1% -$6.61K ﹤0.01% 2478
2018
Q4
$2.17M Sell
1,128,641
-25,697
-2% -$49.3K ﹤0.01% 3002
2018
Q3
$4.36M Buy
1,154,338
+46,394
+4% +$175K ﹤0.01% 2762
2018
Q2
$3.46M Buy
1,107,944
+97,997
+10% +$306K ﹤0.01% 2899
2018
Q1
$2.41M Buy
1,009,947
+185,639
+23% +$444K ﹤0.01% 3005
2017
Q4
$3.22M Buy
824,308
+12,795
+2% +$50K ﹤0.01% 2858
2017
Q3
$2.05M Buy
811,513
+8,947
+1% +$22.5K ﹤0.01% 3160
2017
Q2
$2.22M Buy
802,566
+691,238
+621% +$1.91M ﹤0.01% 3112
2017
Q1
$217K Buy
111,328
+10,932
+11% +$21.3K ﹤0.01% 3771
2016
Q4
$105K Sell
100,396
-27,188
-21% -$28.4K ﹤0.01% 3888
2016
Q3
$139K Buy
127,584
+37,217
+41% +$40.5K ﹤0.01% 3818
2016
Q2
$64K Sell
90,367
-673,453
-88% -$477K ﹤0.01% 3975
2016
Q1
$893K Sell
763,820
-288
-0% -$337 ﹤0.01% 3291
2015
Q4
$1.87M Buy
764,108
+595
+0.1% +$1.46K ﹤0.01% 3095
2015
Q3
$2.29M Buy
763,513
+621,185
+436% +$1.86M ﹤0.01% 2969
2015
Q2
$588K Buy
142,328
+45,899
+48% +$190K ﹤0.01% 3519
2015
Q1
$418K Sell
96,429
-525
-0.5% -$2.28K ﹤0.01% 3657
2014
Q4
$288K Buy
96,954
+7,540
+8% +$22.4K ﹤0.01% 3704
2014
Q3
$297K Sell
89,414
-2,228
-2% -$7.4K ﹤0.01% 3715
2014
Q2
$232K Buy
91,642
+14,856
+19% +$37.6K ﹤0.01% 3816
2014
Q1
$174K Buy
76,786
+10,743
+16% +$24.3K ﹤0.01% 3821
2013
Q4
$129K Buy
66,043
+10,158
+18% +$19.8K ﹤0.01% 3818
2013
Q3
$171K Buy
55,885
+12,979
+30% +$39.7K ﹤0.01% 3696
2013
Q2
$38K Buy
+42,906
New +$38K ﹤0.01% 3958